Franklin David Rumjanek

Franklin David Rumjanek

Auto-generated profile, based on publicly available information

Franklin David Rumjanek

Universidade Federal do Rio de Janeiro, IBqM

Research Focus & Metrics

Academic Career Length

51Years (1976-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 1976 in European Journal of Biochemistry
Verified
Journal Article
Closed access
PDF file
JGJack Gauldie
Jack Gauldie
JHJennifer M. Hanson
Jennifer M. Hanson
FRFranklin D. Rumjanek
Franklin D. Rumjanek
RSRudolf A. Shipolini
Rudolf A. Shipolini
CVCharles A. Vernon
Charles A. Vernon

1 November 2000 in Molecular and Biochemical Parasitology
Verified
Journal Article
Closed access
MOMarcus F. Oliveira
Marcus F. Oliveira
Joana D'AvilaJoana D'Avila
Joana D'Avila
CTChristiane R Torres
Christiane R Torres
POPedro Vitoriano Oliveira
Pedro Vitoriano Oliveira
ATAntônio J Tempone
Antônio J Tempone
SFSérgio T Ferreira
Sérgio T Ferreira

15 November 2013 in Bioscience Reports
Verified
Journal Article
Open access
PDF file
NANívea Dias Amoêdo
Nívea Dias Amoêdo
JVJuan Perez Valencia
Juan Perez Valencia
MRMariana Figueiredo Rodrigues
Mariana Figueiredo Rodrigues
AGAntonio Galina
Antonio Galina
FRFranklin David Rumjanek
Franklin David Rumjanek
Tumour cells thrive in environments that would be hostile to their normal cell counterparts. Survival depends on the selection of cell lines that harbour modifications of both, gene regulation that shifts the balance between the cell cycle and apoptosis and those that involve the plasticity of the metabolic machinery. With regards to metabolism, the selected phenotypes usually display enhanced anaerobic glycolysis even in the presence of oxygen, the so-called Warburg effect, and anabolic pathways that provide precursors for the synthesis of lipids, proteins and DNA. The review will discuss the original ideas of Otto Warburg and how they initially led to the notion that mitochondria of tumour cells were dysfunctional. Data will be presented to show that not only the organelles are viable and respiring, but that they are key players in tumorigenesis and metastasis. Likewise, interconnecting pathways that stand out in the tumour phenotype and that require intact mitochondria such as glutaminolysis will be addressed. Furthermore, comments will be made as to how the peculiarities of the biochemistry of tumour cells renders them amenable to new forms of treatment by highlighting possible targets for inhibitors. In this respect, a case study describing the effect of a metabolite analogue, the alkylating agent 3BP (3-bromopyruvate), on glycolytic enzyme targets will be presented.

1 January 1980 in Molecular and Biochemical Parasitology
Verified
Journal Article
Closed access
FRF.D. Rumjanek
F.D. Rumjanek
ASA.J.G. Simpson
A.J.G. Simpson

15 August 2004 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
MOMarcus F. Oliveira
Marcus F. Oliveira
Joana D'AvilaJoana D'Avila
Joana D'Avila
ATAntônio J. Tempone
Antônio J. Tempone
JSJuliana B. R. Corrêa Soares
Juliana B. R. Corrêa Soares
FRFranklin D. Rumjanek
Franklin D. Rumjanek
POPedro Vitoriano Oliveira
Pedro Vitoriano Oliveira
Adult Schistosoma mansoni digest large amounts of host hemoglobin and release potentially toxic heme inside their guts. We have previously demonstrat

18 July 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
NANívea Dias Amoêdo
Nívea Dias Amoêdo
MRMariana Figueiredo Rodrigues
Mariana Figueiredo Rodrigues
PPPaula Pezzuto
Paula Pezzuto
AGAntonio Galina
Antonio Galina
RCRodrigo Madeiro da Costa
Rodrigo Madeiro da Costa
FRFranklin David Rumjanek
Franklin David Rumjanek
Tumor cells are characterized by accelerated growth usually accompanied by up-regulated pathways that ultimately increase the rate of ATP production. These cells can suffer metabolic reprogramming, resulting in distinct bioenergetic phenotypes, generally enhancing glycolysis channeled to lactate production. In the present work we showed metabolic reprogramming by means of inhibitors of histone deacetylase (HDACis), sodium butyrate and trichostatin. This treatment was able to shift energy metabolism by activating mitochondrial systems such as the respiratory chain and oxidative phosphorylation that were largely repressed in the untreated controls. Various cellular and biochemical parameters were evaluated in lung cancer H460 cells treated with the histone deacetylase inhibitors (HDACis), sodium butyrate (NaB) and trichostatin A (TSA). NaB and TSA reduced glycolytic flux, assayed by lactate release by H460 cells in a concentration dependent manner. NaB inhibited the expression of glucose transporter type 1 (GLUT 1), but substantially increased mitochondria bound hexokinase (HK) activity. NaB induced increase in HK activity was associated to isoform HK I and was accompanied by 1.5 fold increase in HK I mRNA expression and cognate protein biosynthesis. Lactate dehydrogenase (LDH) and pyruvate kinase (PYK) activities were unchanged by HDACis suggesting that the increase in the HK activity was not coupled to glycolytic flux. High resolution respirometry of H460 cells revealed NaB-dependent increased rates of oxygen consumption coupled to ATP synthesis. Metabolomic analysis showed that NaB altered the glycolytic metabolite profile of intact H460 cells. Concomitantly we detected an activation of the pentose phosphate pathway (PPP). The high O2 consumption in NaB-treated cells was shown to be unrelated to mitochondrial biogenesis since citrate synthase (CS) activity and the amount of mitochondrial DNA remained unchanged. NaB and TSA induced an increase in mitochondrial function and oxidative metabolism in H460 lung tumor cells concomitant with a less proliferative cellular phenotype.